Posted by Michael Wonder on 17 Jun 2020
Proposal relating to Schedule changes made in response to COVID-19
17 June 2020 - Over the last few months, PHARMAC has amended or removed funding criteria for many pharmaceuticals in order to help improve access to these treatments in anticipation of and/or response to COVID-19 impacts on the health sector.
PHARMAC is now working to determine the longer-term funding arrangements for these pharmaceuticals, and are seeking feedback from stakeholders on:
- A proposal to maintain these changes for some products indefinitely
- A timeline for resumption of previous criteria for other products
